IV Therapy Complications: What Healthcare Professionals Need to Recognize

The CBAM Four-Layer IV Safety Model

Rather than memorizing complications as an isolated list, think about IV safety across four layers:

Ask four questions:

• Patient: Is this treatment appropriate for this person?
• Access: Is vascular access safe and functioning?
• Infusion: Is the treatment itself appropriate?
• Monitoring: Are changes being recognized early?

IV Therapy Safety Starts Before the IV

When clinicians think about IV complications, they often think first about what happens around the catheter: swelling, pain, redness, leakage or loss of flow.

Those matter.

But they represent only one part of the safety equation.

Consider two patients. The first develops infiltration despite otherwise appropriate treatment. The second has perfectly functioning vascular access—but the treatment being administered is inappropriate for their clinical situation.

Both represent IV safety problems. Only one is primarily a catheter problem.

This distinction is important because IV therapy combines at least four clinical elements:

• the patient,
• the vascular access,
• the substance being administered,
• and the patient's response to treatment.

That is why complication prevention should begin with assessment rather than insertion.

How Common Are Peripheral IV Complications?

Peripheral IV catheters are used extensively throughout healthcare. Yet catheter failure is not unusual.

A 2024 systematic review and meta-analysis evaluated 69 studies representing 478,586 peripheral intravenous catheters. The researchers found that all-cause peripheral IV catheter failure before treatment completion occurred in approximately 36.4% of catheters.

Catheter-associated bloodstream infection was much less common—approximately 0.028% per catheter in the pooled analysis.

The numbers reveal an important clinical distinction:

Understanding Each Layer of IV Safety

Layer 1 — Patient

Should this patient receive this treatment?

Potential considerations may include:

• medical history;
• medications and supplements;
• allergies;
• previous reactions;
• cardiovascular considerations;
• renal considerations;
• pregnancy where relevant;
• relevant laboratory information where indicated;
• the reason for treatment;
• treatment-specific contraindications.

Layer 2 — Access

Is vascular access safe and functioning appropriately?

This layer includes complications such as infiltration, extravasation, phlebitis, hematoma, occlusion, leakage, dislodgement and catheter failure.

The catheter site therefore needs ongoing assessment rather than a one-time check after insertion. CDC guidance recommends evaluation of peripheral catheter sites and removal when signs of phlebitis, infection or catheter malfunction develop.

Layer 3 — Infusion

Is the substance and treatment plan appropriate?

Risk can also relate to:

• what is being administered;
• volume;
• concentration;
• compatibility;
• treatment-specific contraindications;
• potential interactions;
• patient-specific tolerance.

The same vascular access can carry very different clinical implications depending on what is being infused.

Layer 4 — Monitoring

Is a developing problem being recognized early?

The patient's condition and the IV site can change after treatment begins. Monitoring therefore asks:

• Has the site changed?
• Has pain increased?
• Has swelling developed?
• Has flow changed?
• Has the patient's condition changed?
• Have systemic symptoms appeared?
• Is the treatment proceeding as expected?

The safety system fails if nobody recognizes the change.

Detailed Look at Specific Complications

1. Infiltration: When Fluid Leaves the Intended Vascular Space

Infiltration occurs when IV fluid unintentionally enters surrounding tissue rather than remaining within the intended vein. The presentation can vary depending on factors such as site, volume, duration, catheter position and characteristics of the fluid.

Possible local changes may include swelling, discomfort, coolness, leakage, changes in flow and altered appearance around the insertion site.

2. Extravasation: Why the Infusate Matters

Infiltration and extravasation are sometimes discussed as though they mean exactly the same thing. Clinically, the distinction matters.

Extravasation generally refers to unintended leakage of an infusate capable of causing greater local tissue injury. This introduces an important principle:

3. Phlebitis: More Than Redness Around an IV

Phlebitis refers to inflammation of a vein. It may be influenced by multiple factors rather than one single cause. These can include:

• Mechanical factors — Movement or physical irritation associated with the catheter.
• Chemical factors — Characteristics of the administered substance.
• Patient-related factors — Individual vascular and clinical characteristics.

Possible findings may include pain, tenderness, warmth, erythema or changes along the vein. CDC guidance specifically identifies warmth, tenderness, erythema and a palpable venous cord among signs that should prompt removal of a peripheral venous catheter.

4. Occlusion: When Normal Catheter Function Changes

A catheter that suddenly stops functioning normally should not simply be considered inconvenient. A change in flow is information.

The clinically useful question is not: "How do I make it flow again?" The first question should be: "Why has normal function changed?"

5. Dislodgement and Leakage

Peripheral IV catheters exist within a moving patient. Movement, inadequate securement or changes around the insertion site can affect catheter position and function.

Possible consequences can include leakage, interrupted therapy, infiltration, loss of vascular access and need for catheter replacement.

Securement therefore may look like a small operational detail, but it contributes to a much larger safety system. The catheter must not simply be inserted successfully. It has to remain appropriately positioned and functional.

6. Hematoma and Local Bleeding

Establishing vascular access requires vessel puncture. Local bleeding and hematoma can therefore occur. The significance of these complications can differ according to patient characteristics.

Before treatment, relevant considerations may include medication history, anticoagulant or antiplatelet use where relevant, previous bleeding problems, vascular fragility, previous access difficulties and underlying medical conditions.

Again, the pattern becomes clear: Complication prevention begins before the needle reaches the skin.

7. Infection: Uncommon Per Catheter, Important at Scale

Infection deserves separate attention because frequency and severity can easily be confused. The large 2024 systematic review found catheter-associated bloodstream infection in approximately 0.028% of peripheral IV catheters, while local infection was estimated at approximately 0.15%.

Those percentages appear small. But peripheral IV catheters are used on an enormous scale globally. Even a relatively uncommon event can therefore create a substantial clinical burden.

Infection prevention is consequently not limited to checking for redness after insertion. It involves a chain of safeguards:

CDC recommendations emphasize hand hygiene, aseptic technique, trained personnel and ongoing catheter-site assessment as core elements of intravascular catheter safety.

8. Adverse Reactions: When the Catheter Isn't the Problem

This is one of the most important distinctions for clinicians working in IV wellness, longevity and aesthetic settings. Sometimes the vascular access is functioning perfectly. The problem is the patient's response to what is being administered.

Depending on the treatment, relevant considerations can include allergy history, current medications, medical conditions, previous infusion reactions, ingredients, dose, volume, potential interactions and treatment-specific contraindications.

9. Fluid-Related Risk

Another common oversimplification is assuming that because a fluid is routinely used, it carries the same risk for every patient. It does not. Volume and composition may have different implications in patients with certain cardiovascular, renal or other medical conditions.

The Most Important IV Safety Step May Happen Before Insertion

Suppose a practitioner performs technically excellent vascular access. The catheter is secure. There is no infiltration. There is no phlebitis. Everything appears perfect.

But the patient should never have received that particular treatment.

Was the procedure safe?

No.

This illustrates why pre-treatment assessment belongs at the center of IV safety.

Depending on the treatment and clinical context, assessment may consider:

• medical history;
• current medications;
• supplements;
• known allergies;
• previous infusion reactions;
• renal history;
• cardiovascular history;
• treatment objective;
• pregnancy where relevant;
• relevant laboratory findings where indicated;
• contraindications associated with the proposed treatment.

Our dedicated article on Patient Assessment Before IV Therapy explores this part of the pathway in greater detail.

For the broader topic, the CBAM IV Therapy Guide connects patient assessment with IV principles, clinical applications, safety and treatment considerations.

Prevention Is a System, Not a Checklist

Healthcare professionals naturally like checklists. They are useful. But IV safety is better understood as a connected system:

A weakness anywhere in that chain can increase risk. This is one reason why teaching only "how to start an IV" provides an incomplete understanding of IV therapy.

What Does the Evidence Say About Prevention?

This is an area where clinicians should also be careful not to overstate certainty. A 2024 systematic review examined 105 studies assessing infection-prevention and complication-reduction interventions for peripheral IV catheters. The researchers found varying levels of evidence across interventions and highlighted significant gaps in high-quality research for several commonly used measures.

That matters. Not every routine practice has the same level of supporting evidence.

At the same time, established infection-control principles remain important. CDC recommendations include healthcare-worker education, demonstrated competence, appropriate catheter selection, hand hygiene, aseptic technique and regular site assessment.

Expected Treatment Experience or Developing Complication?

One of the harder skills in clinical practice is recognizing when something has changed. Rather than memorizing only individual warning signs, practitioners can repeatedly ask:

Has the site changed?

• New swelling?
• New redness?
• New leakage?

Has the sensation changed?

• Increasing discomfort?
• Tenderness?
• Unexpected pain?

Has the catheter changed?

• Different flow?
• Resistance?
• Loss of function?

Has the patient changed?

• New systemic symptoms?
• Unexpected response?
• Change from baseline?

This approach makes monitoring dynamic. The practitioner is not simply looking for a predefined complication. They are looking for deviation from the expected course.

The Difference Between a Protocol and Clinical Reasoning

Protocols are valuable. They help standardize care and reduce unnecessary variation. But a protocol cannot represent every patient.

Consider the difference between these two approaches:

The second practitioner understands the system behind the protocol. That distinction becomes particularly important when something unexpected occurs.

When Does an IV Problem Become an Escalation Problem?

Not every complication has the same clinical significance. Some issues may be localized and readily addressed within the practitioner's authorized clinical role. Others may require another clinician, medical evaluation, urgent escalation or emergency services.

A clinic offering IV therapy should therefore establish its escalation pathway before an adverse event occurs. Practitioners should know:

• which events they are authorized and trained to manage;
• when treatment should be discontinued;
• when another clinician should become involved;
• when urgent or emergency assessment is necessary;
• how the event should be documented;
• what follow-up is required.

Why This Matters Beyond Hospitals

IV therapy is no longer confined to inpatient medical environments. It is increasingly encountered in wellness clinics, aesthetic practices, longevity medicine, integrative medicine, hydration clinics and mobile IV services.

The environment may feel different from a hospital. The basic principles of clinical safety do not disappear.

A responsible IV program therefore needs more than a treatment menu. It needs systems for:

• patient selection
• documentation
• infection prevention
• treatment governance
• monitoring
• adverse-event recognition
• emergency preparedness
• scope of practice
• and quality assurance

Where IV Therapy Training Fits

Healthcare professionals who want to develop competence in IV therapy need more than isolated complication knowledge. A structured educational pathway should connect:

Healthcare professionals seeking focused education in this area can explore CBAM's IV Therapy Certificate Course Online.

For a broader educational overview before considering a course, start with the CBAM IV Therapy Guide.

From Knowing Complications to Understanding Why They Happen

There is a major difference between being able to list: "infiltration, phlebitis, infection, occlusion…" and understanding:

• Why did the problem occur?
• Could the risk have been identified earlier?
• Was the patient appropriately selected?
• Was vascular access functioning normally?
• Did something change during treatment?
• Was the change recognized quickly?
• Was escalation appropriate?

That is where IV education becomes clinically meaningful.

The CBAM Four-Layer Safety Check

If you remember only one framework from this article, remember these four questions:

A complication can emerge at any of these four layers. That is why IV safety cannot begin and end with successful cannulation.

Clinical Takeaways

IV therapy complications should not be understood as a list of isolated adverse events. They belong to a larger clinical system.

Peripheral catheter problems such as infiltration, phlebitis, occlusion and dislodgement are important. So are infection, systemic reactions and treatment-related risks.

But the most important lesson is broader: